Alcohol Clinical Trials in New Haven, Connecticut
20 recruitingNew Haven, Connecticut
Showing 1–20 of 20 trials
Recruiting
Phase 1
Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
Weight LossAlcohol Use DisorderBariatric Surgery Patients
Yale University10 enrolled1 locationNCT07223983
Recruiting
Not Applicable
Implementation Facilitation Pilot for Alcohol Use Disorder (AUD) in Alcohol-associated Liver Disease (ALD)
Alcohol Use DisorderAlcohol Associated Liver Disease
Yale University30 enrolled1 locationNCT07525258
Recruiting
Phase 1
The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)
Alcohol Use Disorder (AUD)Alcohol-Related DisordersAlcohol Use
Yale University63 enrolled1 locationNCT06070649
Recruiting
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Healthy ControlSchizophreniaPost Traumatic Stress Disorder+4 more
Yale University100 enrolled1 locationNCT01730781
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting
Phase 1
Study of NTX-2001 on Alcohol Consumption in Alcohol Use Disorder
Alcohol Use Disorder
Newleos Therapeutics, Inc.50 enrolled1 locationNCT07520292
Recruiting
Phase 1Phase 2
A First in Human Study of CMND-100 in Healthy and Alcohol Use Disorder (AUD) Subjects
Alcohol Use Disorder
Clearmind Medicine Inc.84 enrolled4 locationsNCT05913752
Recruiting
Phase 2
Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
Alcohol Use
Yale University160 enrolled1 locationNCT03764098
Recruiting
Phase 2
Pregnenolone for the Treatment of Alcohol Use Disorder
Alcohol Use Disorder
Yale University150 enrolled1 locationNCT05781009
Recruiting
Not Applicable
Promoting Alcohol Treatment Engagement Post-hospitalization
Alcohol Use Disorder
Yale University450 enrolled1 locationNCT05338151
Recruiting
Phase 2
Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
alcohol withdrawal
Yale University150 enrolled2 locationsNCT04793685
Recruiting
Phase 2
Digoxin In NASH (CODIN)
MASLDMASH - Metabolic Dysfunction-Associated SteatohepatitisFatty Liver Disease+5 more
Yale University144 enrolled2 locationsNCT06588699
Recruiting
Phase 1
Influence of Mavoglurant on Alcohol Craving and Drinking in Heavy Drinkers
Heavy DrinkerAlcohol ConsumptionAlcohol Use Disorder (AUD)
Yale University63 enrolled2 locationsNCT06136195
Recruiting
Not Applicable
Drinking, Acetate, and Stress
Alcohol Use DisorderAlcohol Use, UnspecifiedHeavy Drinker+1 more
Yale University50 enrolled2 locationsNCT06584448
Recruiting
Not Applicable
Developing a Novel Human Laboratory Paradigm for AUD Medication Screening
Alcohol Use Disorder
Yale University90 enrolled1 locationNCT06489782
Recruiting
Imaging Traumatic Stress and Alcohol Use Disorder With [18F]Bavarostat
Post Traumatic Stress DisorderAlcohol Use Disorder
Yale University150 enrolled1 locationNCT06371404
Recruiting
Phase 3
Emergency Department-Initiated Medications for Alcohol Use Disorder
Alcohol Use Disorder
Yale University240 enrolled1 locationNCT05827159
Recruiting
Phase 2
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Early Phase 1
Investigating the Mu:Kappa Opioid Receptor Imbalance in Alcohol Use Disorder
Alcohol Use Disorder
Yale University100 enrolled1 locationNCT05957159
Recruiting
Not Applicable
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
HIV InfectionsAlcohol Use DisorderRisk Behavior
University of Kentucky405 enrolled2 locationsNCT05576350